Stock Region Penny Picks
Your Weekend Penny Picks Watchlist is Here!
Your Weekend Penny Picks Watchlist Is Here!
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Hey Stock Region Crew,
Welcome to your weekend watchlist! Before we dive in, a quick but important reminder: this is an opinion-based newsletter for entertainment and informational purposes only. The content here is not financial advice. Always do your own research and consult with a professional before making any investment decisions. Trading stocks, especially low-float and small-cap stocks, carries significant risk.
Now, let’s get to the good stuff. What a wild week it has been! We saw some incredible moves, and a few tickers have caught my eye for potential action next week. Here’s what’s on my radar.
The Watchlist Breakdown
$MOBX - Mobix Labs
These guys are not playing around. Mobix announced an aggressive acquisition strategy with access to over $100 million. This tells me they’re hungry for growth and looking to expand their footprint in a big way. A move like this can be a massive catalyst. I’m watching this one closely to see how they start deploying that capital. Aggression can pay off.
$OVID - Ovid Therapeutics
Biotech alert! Ovid dropped positive topline results for its new inhibitor, OV329. The key takeaways were “strong inhibitory activity” and a “potential best-in-category safety profile.” In the biotech world, data is king, and positive results like these can send a stock flying. Safety is a huge hurdle, so clearing it is a significant win. Definitely one to watch for follow-through momentum.
$UMAC - Unusual Machines
Drones are a hot sector, and Unusual Machines just secured an $800,000 order from Red Cat for high-performance components. This isn’t just a sale; it’s a validation of their tech from another key player in the industry. It shows their products are in demand. I love seeing these kinds of B2B wins—it signals real, fundamental strength.
$KIDZ - Classover
This one is interesting. Classover is now accepting Solana ($SOL) and beefing up its treasury strategy with the crypto. Being one of the first Nasdaq-listed companies to embrace SOL this directly is a bold, forward-thinking move. It puts them on the map for both the equity and crypto crowds. It’s a bit of a high-risk, high-reward play, but it definitely has my attention.
$ANRO - Alto Neuroscience
Another biotech making waves! Alto received FDA Fast Track Designation for ALTO-101. This is a big deal. Fast Track is designed to get important new drugs to patients earlier. For investors, it means a potentially quicker path to approval and revenue. This designation is a huge de-risking event and shows the FDA sees the potential here.
$COSM - Cosmos Health
Cosmos is going global! They just expanded their Sky Premium Life brand into the billion-dollar Kuwait market. They signed an exclusive distribution deal and already have an initial purchase order for over 65,000 units. This is fantastic news. It’s not just a plan; it’s a done deal with revenue attached. International expansion can be a powerful growth driver.
$CETY - Clean Energy Technologies
Clean energy is always on my radar. CETY delivered a breakthrough ORC project in Tennessee. This isn’t just another press release; it’s a real-world application of their waste-heat-to-power technology. Successful project delivery builds credibility and can lead to more contracts. It proves the tech works and makes money.
$INTJ - INTJ
INTJ is getting into the education game by investing in “Aether Education,” a premium consulting firm. This is a pivot into a stable, high-margin industry. They are diversifying their portfolio, which can be a smart long-term strategy. I’ll be watching to see how this investment plays out and contributes to their bottom line.
That’s a wrap for this week’s watchlist! Keep these tickers on your screen. As always, manage your risk, have a plan, and never invest more than you are willing to lose.
Happy trading!
Disclaimer: The information provided in this newsletter is for informational and entertainment purposes only. It is not intended to be and does not constitute financial advice or any other advice. The author is not a financial advisor. All opinions expressed are the author’s own. You should not make any decision, financial, investment, trading or otherwise, based on any of the information presented in this newsletter without undertaking independent due diligence and consultation with a professional broker or financial advisor. You understand that you are using any and all information available on or through this newsletter at your own risk.